Laureano Simón Buela
Directeur Général chez Oncomatryx Biopharma SL
Profil
Laureano Simón Buela is the founder and CEO of Oncomatryx Biopharma SL, which was founded in 2009.
He is also the founder of BRAINco Biopharma SL.
Currently, he holds the position of Director at StemTek Therapeutics SL, Director at Patia Europe SL, and President at Nelum Corp.
In the past, he worked as the Managing Director and Director at Progenika Biopharma SA. Dr. Simón Buela has a graduate degree from the University of Wisconsin, the University of Navarra, and the University of Santiago de Compostela.
He also has a doctorate degree from Universidad Autónoma de Madrid.
Postes actifs de Laureano Simón Buela
| Sociétés | Poste | Début |
|---|---|---|
Oncomatryx Biopharma SL
 Oncomatryx Biopharma SL Pharmaceuticals: MajorHealth Technology Oncomatryx Biopharma SL develops drugs for the treatment of cancer. It also develops biological medications and diagnostic kits to treat invasive states of breast cancer and cancer of the pancreas. The company was founded by Manuel Sanz Vazquez and Buela Laureano Simon in 2009 and is headquartered in Derio, Spain. | Directeur Général | 01/01/2009 |
StemTek Therapeutics SL
 StemTek Therapeutics SL BiotechnologyHealth Technology StemTek Therapeutics SL is a biopharmaceutical company. It provides research services portfolio in drug development for cancer treatment. The company offers screening and custom services. StemTek Therapeutics was founded by Angel García Martín, Olatz Leis Esnaola, and Gabriel Inclan Blanco in 2013 and is headquartered in Derio, Spain. | Directeur/Membre du Conseil | 01/01/2016 |
Nelum Corp.
 Nelum Corp. Pharmaceuticals: MajorHealth Technology Nelum Corp. operates as a clinical stage biopharmaceutical firm. Its focus areas include cancer and fibrosis. The company is headquartered in Durham, NC. | President | - |
Patia Europe SL
 Patia Europe SL Miscellaneous Commercial ServicesCommercial Services Patia Europe SL is a public health company based in Donostia-San Sebastián, Spain. The Spanish company integrates genetic, metabolomic, and digital tools to facilitate the prevention and control of type 2 diabetes. Patia's team has extensive experience in the fields of molecular biology and genomic medicine, complemented by top-level alliances with prestigious research centers in and the Americas to make the most advanced genomic and technological tools available to the population in the most accessible way. Patia offers a laboratory test called Diabetespredict™, which provides an evaluation of high sensitivity and specificity of the genetic predisposition to develop type 2 diabetes (DT2). Additionally, it offers personalized recommendations based on the patient's genetics. The test has been developed in collaboration with scientists and endocrinologists from the Hospital General de. Patia also works to reduce the effects of the COVID-19 pandemic on people with diabetes. | Directeur/Membre du Conseil | 29/02/2016 |
Anciens postes connus de Laureano Simón Buela
| Sociétés | Poste | Fin |
|---|---|---|
Progenika Biopharma SA
 Progenika Biopharma SA Medical SpecialtiesHealth Technology Progenika Biopharma SA engages in the design and development of molecular biology testing solutions. The firm offers ID Core Control, ID RHD, ID Core, SeqPro Lipo IS, and A1AT genotyping test. The company was founded in 2000 and is headquartered in Derio, Spain. | Directeur Général | 22/05/2013 |
BRAINco Biopharma SL
 BRAINco Biopharma SL Medical SpecialtiesHealth Technology BRAINco Biopharma SL develops and produces diagnosis and treatment for neurological and psychiatric diseases. It develops drugs directed against therapeutic targets and diagnostic biochips, prognosis, and prediction of individual response to drug treatment. The company was founded by Laureano Simon Buela in 2008 and is headquartered in Bilbao, Spain. | Fondateur | - |
Formation de Laureano Simón Buela
| University of Wisconsin | Graduate Degree |
| University of Navarra | Graduate Degree |
| University of Santiago de Compostela | Graduate Degree |
| Universidad Autónoma de Madrid | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
BRAINco Biopharma SL
BRAINco Biopharma SL Medical SpecialtiesHealth Technology BRAINco Biopharma SL develops and produces diagnosis and treatment for neurological and psychiatric diseases. It develops drugs directed against therapeutic targets and diagnostic biochips, prognosis, and prediction of individual response to drug treatment. The company was founded by Laureano Simon Buela in 2008 and is headquartered in Bilbao, Spain. | Health Technology |
Progenika Biopharma SA
Progenika Biopharma SA Medical SpecialtiesHealth Technology Progenika Biopharma SA engages in the design and development of molecular biology testing solutions. The firm offers ID Core Control, ID RHD, ID Core, SeqPro Lipo IS, and A1AT genotyping test. The company was founded in 2000 and is headquartered in Derio, Spain. | Health Technology |
Oncomatryx Biopharma SL
Oncomatryx Biopharma SL Pharmaceuticals: MajorHealth Technology Oncomatryx Biopharma SL develops drugs for the treatment of cancer. It also develops biological medications and diagnostic kits to treat invasive states of breast cancer and cancer of the pancreas. The company was founded by Manuel Sanz Vazquez and Buela Laureano Simon in 2009 and is headquartered in Derio, Spain. | Health Technology |
StemTek Therapeutics SL
StemTek Therapeutics SL BiotechnologyHealth Technology StemTek Therapeutics SL is a biopharmaceutical company. It provides research services portfolio in drug development for cancer treatment. The company offers screening and custom services. StemTek Therapeutics was founded by Angel García Martín, Olatz Leis Esnaola, and Gabriel Inclan Blanco in 2013 and is headquartered in Derio, Spain. | Health Technology |
Patia Europe SL
Patia Europe SL Miscellaneous Commercial ServicesCommercial Services Patia Europe SL is a public health company based in Donostia-San Sebastián, Spain. The Spanish company integrates genetic, metabolomic, and digital tools to facilitate the prevention and control of type 2 diabetes. Patia's team has extensive experience in the fields of molecular biology and genomic medicine, complemented by top-level alliances with prestigious research centers in and the Americas to make the most advanced genomic and technological tools available to the population in the most accessible way. Patia offers a laboratory test called Diabetespredict™, which provides an evaluation of high sensitivity and specificity of the genetic predisposition to develop type 2 diabetes (DT2). Additionally, it offers personalized recommendations based on the patient's genetics. The test has been developed in collaboration with scientists and endocrinologists from the Hospital General de. Patia also works to reduce the effects of the COVID-19 pandemic on people with diabetes. | Commercial Services |
Nelum Corp.
Nelum Corp. Pharmaceuticals: MajorHealth Technology Nelum Corp. operates as a clinical stage biopharmaceutical firm. Its focus areas include cancer and fibrosis. The company is headquartered in Durham, NC. | Health Technology |
